Australia's most trusted
source of pharma news
Monday, 02 February 2026
Posted 30 January 2026 AM
A new wave of treatments is coming to fruition, many of which are forecast to surpass US$1 billion in the G7 countries alone in 2031.
Clarivate has released a list of 11 Drugs to Watch in 2026 as they begin their blockbuster run and/or transform treatment paradigms over the next five years. The list showcases drugs recently launched overseas and drugs likely to enter the market or meet consequential milestones this year.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.